170 related articles for article (PubMed ID: 24400545)
1. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 4. Macrophage activating syndrome and hemophagocytic syndrome].
Komagata Y
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2639-44. PubMed ID: 24400545
[No Abstract] [Full Text] [Related]
2. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
[TBL] [Abstract][Full Text] [Related]
3. Interferon-γ blockade in CAR T-cell therapy-associated macrophage activation syndrome/hemophagocytic lymphohistiocytosis.
Rainone M; Ngo D; Baird JH; Budde LE; Htut M; Aldoss I; Pullarkat V
Blood Adv; 2023 Feb; 7(4):533-536. PubMed ID: 35917457
[No Abstract] [Full Text] [Related]
4. UNC13D mutation in a patient with juvenile polymyositis with recurrent macrophage activation syndrome.
Yang X; Yao H; Zhao Q; Zhao Q; Yan X; Zhang Z; Kong P; Zhang X; Kanegane H; Zhao X; Tang X
Rheumatology (Oxford); 2021 Nov; 60(11):e404-e406. PubMed ID: 33930104
[No Abstract] [Full Text] [Related]
5. Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy.
Griffin G; Shenoi S; Hughes GC
Best Pract Res Clin Rheumatol; 2020 Aug; 34(4):101515. PubMed ID: 32387063
[TBL] [Abstract][Full Text] [Related]
6. Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults.
Hines MR; von Bahr Greenwood T; Beutel G; Beutel K; Hays JA; Horne A; Janka G; Jordan MB; van Laar JAM; Lachmann G; Lehmberg K; Machowicz R; Miettunen P; La Rosée P; Shakoory B; Zinter MS; Henter JI
Crit Care Med; 2022 May; 50(5):860-872. PubMed ID: 34605776
[TBL] [Abstract][Full Text] [Related]
7. Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes.
Canna SW; Behrens EM
Pediatr Clin North Am; 2012 Apr; 59(2):329-44. PubMed ID: 22560573
[TBL] [Abstract][Full Text] [Related]
8. Hemophagocytic lymphohistiocytosis in adults: diagnosis and treatment.
Larroche C
Joint Bone Spine; 2012 Jul; 79(4):356-61. PubMed ID: 22464018
[TBL] [Abstract][Full Text] [Related]
9. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: I. Damage to important organs whose early treatment makes a big difference; 6. Hematopoiesis].
Dobashi H; Kameda T
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2575-81. PubMed ID: 24400537
[No Abstract] [Full Text] [Related]
10. The hemophagocytic syndrome/macrophage activation syndrome: a final common pathway of a cytokine storm.
Szyper-Kravitz M
Isr Med Assoc J; 2009 Oct; 11(10):633-4. PubMed ID: 20077953
[No Abstract] [Full Text] [Related]
11. Macrophage Activation Syndrome in Children: Diagnosis and Management.
Bagri NK; Gupta L; Sen ES; Ramanan AV
Indian Pediatr; 2021 Dec; 58(12):1155-1161. PubMed ID: 33772536
[TBL] [Abstract][Full Text] [Related]
12. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 1. Pulmonary hypertension associated with connective tissue diseases].
Tanaka S
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2613-20. PubMed ID: 24400542
[No Abstract] [Full Text] [Related]
13. Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis.
Weaver LK; Behrens EM
Curr Opin Rheumatol; 2014 Sep; 26(5):562-9. PubMed ID: 25022357
[TBL] [Abstract][Full Text] [Related]
14. Coagulation Disorders in Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome.
Valade S; Mariotte E; Azoulay E
Crit Care Clin; 2020 Apr; 36(2):415-426. PubMed ID: 32172822
[TBL] [Abstract][Full Text] [Related]
15. [Hemophagocytic lymphohistiocytosis].
Imamura Y
Rinsho Ketsueki; 2014 Feb; 55(2):223-33. PubMed ID: 24598190
[No Abstract] [Full Text] [Related]
16. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 5. Pregnancy in autoimmune rheumatic diseases].
Murakawa Y
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2645-52. PubMed ID: 24400546
[No Abstract] [Full Text] [Related]
17. High-Volume Hemofiltration in Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Prospective Study in the PICU.
Cui Y; Zhang YC; Kang YL; Ren YQ; Miao HJ; Wang F
Pediatr Crit Care Med; 2016 Oct; 17(10):e437-e443. PubMed ID: 27487914
[TBL] [Abstract][Full Text] [Related]
18. Not all hemophagocytes are created equally: appreciating the heterogeneity of the hemophagocytic syndromes.
Canna SW; Behrens EM
Curr Opin Rheumatol; 2012 Jan; 24(1):113-8. PubMed ID: 22089101
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and treatment of hemophagocytic syndrome].
Kawa K; Sakata A; Takeshita Y; Inoue M
Rinsho Ketsueki; 2005 Jun; 46(6):418-23. PubMed ID: 16447723
[No Abstract] [Full Text] [Related]
20. Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management.
Henderson LA; Cron RQ
Paediatr Drugs; 2020 Feb; 22(1):29-44. PubMed ID: 31732958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
